Overview

Presents an up-to-date treatment of research strategies, clinical and commercial developments, and regulatory and economic issues pertaining to the formulation of effective and safe red blood cell substitutes.

Focus Areas

The text examines regulatory and socioeconomic aspects of blood substitute products, and global transfusion practices from the perspective of